Games Global Ltd (Ticker: GGL US) is an online gaming content company incorporated in the Isle of Man. Games Global develops, distributes, and markets a diverse range of online casino-style gaming content and integrated business-to-business solutions to iGaming operators globally. The company boasts one of the largest networks of exclusive iGaming content studios, offering over 1,300 proprietary games developed by its 40 in-house and partnered studios. Games Global's portfolio includes slot games, table games, video poker, video bingo, game show games, crash games, and live casino games.

Games Global Ltd will list on the New York Stock Exchange (NYSE) on May 14, 2024. The company plans to offer 14.5 million shares, priced between USD 16.00 and USD 19.00. The total offer size is estimated to be USD 253.75 million if priced at the midpoint of USD 17.50 per share. The offering includes 6.0 million primary shares and 8.5 million secondary shares offered by selling shareholders. The offering is managed by JP Morgan Securities LLC (Left Lead), Jefferies LLC, Macquarie Capital USA Inc., Barclays, and BTIG.

ZEEKR Intelligent Technology Holding Limited (Ticker: ZK US) is a Chinese technology company focused on the development and production of premium battery electric vehicles (BEVs) and related technology solutions. ZEEKR Intelligent Technology will list on May 10, 2024. The firm is offering 17.5 million American Depository Shares (ADS) at a price range of $18-$21. The expected market capitalization at offer is up to $5 billion. The total offer size is USD $349.08 million. The offering is managed by Goldman Sachs, Morgan Stanley, BofA Securities, and CICC, among others. Notable pre-subscriptions include up to $320.0 million from Geely Auto, approximately $10.0 million from Mobileye, and about $19.08 million from CATL.

Silvaco Group Inc (Ticker: SVCO US) is a software company based in the United States that focuses on electronic design automation (EDA) and semiconductor design IP (SIP). The company plans to list on NASDAQ GS on May 9, 2024. Silvaco Group Inc is offering 6.00 million shares, with an anticipated price range of USD 17.00 to USD 19.00, and aims to raise USD 114.00 million. The IPO is being managed by Jefferies & Co (Left Lead) and Cowen & Co.
Founded in 1984, Silvaco is headquartered in Santa Clara, California, and operates globally with offices across North America, Europe, and Asia. The company offers a range of software products, including EDA and TCAD tools, as well as a wide array of semiconductor design IPs.

Proficient Auto Logistics Inc (Ticker: PAL US) is a United States-based transportation company specializing in automotive logistics. The firm is set to list on NASDAQ GM on May 9, 2024. Proficient Auto Logistics is offering 14.33 million shares with a price range of USD 14.00 to USD 16.00, aiming to raise approximately USD 229.33 million. The IPO is managed by Stifel (Left Lead), Raymond James & Associates, and William Blair & Co LLC. The company has a longstanding history in the automotive transport sector, operating a comprehensive network across the United States to facilitate vehicle logistics.

Viking Holdings Ltd (Ticker: VIK US) is a Switzerland-headquartered company operating in the cruise lines industry. Founded in 1997, the company providing leisure travel services across various global destinations, specializing in luxury river and sea cruises. Viking Holdings Ltd is planning an IPO and expects to raise USD 1.1 billion on the New York Stock Exchange. The company is offering 44.00 million shares, priced between USD 21.00 and USD 25.00 each. The IPO includes 11.00 million primary shares and 33.00 million secondary shares, with an additional greenshoe option of 6.60 million shares. The expected trading date is May 1, 2024.

The offering is managed by BofA Securities, HSBC Securities, JP Morgan Securities, Morgan Stanley, Rothschild Global Investments Inc, Stifel Nicolaus & Co Inc, UBS Securities LLC, and Wells Fargo Capital Finance LLC.

Loar Holdings Inc (Ticker: LOAR US) is an aerospace and defense equipment company that focuses on designing and manufacturing niche aerospace system and parts. Loar Holdings Inc will list on the New York Stock Exchange. The company is set to offer 11 million shares at USD 28.00 per share, aiming to raise approximately USD 308 million. The IPO is scheduled with an expected pricing date of April 25, 2024, and trading is anticipated to commence on April 26, 2024.

The offering is managed by Jefferies LLC as the left lead, alongside Citigroup Global Markets Inc, Moelis & Co, Morgan Stanley & Co Inc, and RBC Capital Markets. An additional 1.65 million shares are available through a greenshoe option, representing 15% of the total shares offered.

Rubrik, Inc. (Ticker: RBRK US) is a company that operates in the cloud data management and data security sector. It provides services to a variety of industries such as government, healthcare, legal, and financial sectors across the globe. Rubrik is planning an IPO on the New York Stock Exchange, with the intention to raise approximately USD 752 million. The company will offer 23.5 million primary shares priced at USD 32.
This IPO is scheduled with the shares expected to begin trading on April 25, 2024. The IPO is being managed by a group of underwriters led by Goldman Sachs, alongside Barclays, Citigroup, and Wells Fargo.

Marex Group plc (Ticker: MRX US) is a diversified global financial services platform headquartered in London, England. The company operates across energy, commodities, and financial markets, offering liquidity, market access, and infrastructure services essential for global exchanges and a range of execution services. Marex Group is set to list on the NASDAQ on April 25, 2024. The firm plans to offer 15.4 million shares, priced at $19 per share, aiming to raise approximately $308 million.

The offering is managed by Barclays, Goldman Sachs, Jefferies, and Keefe, Bruyette & Woods. Of the total shares, Marex is offering 3.85 million shares, while the selling shareholders are offering 11.54 million shares. The company will not receive any proceeds from the shares sold by the selling shareholders.

Centuri Holdings Inc (Ticker: CTRI US) is an engineering and construction company specializing in building and maintaining energy networks across the United States and Canada. This company is a unit of Southwest Gas Holdings and operates with over 12,500 employees in 43 U.S. states and two Canadian provinces. Centuri Holdings Inc plans to list on the New York Stock Exchange.
The IPO is scheduled for April 18, 2024, with an expected price range of USD 18.00 to 21.00 per share. The company is offering 12.4 million shares and aims to raise approximately USD 260.4 million. Additionally, a greenshoe option of 1.86 million shares is available, indicating potential for an oversubscription. The IPO is managed by UBS Investment Bank, Baird Holding Co, BofA Securities, JP Morgan, KeyBanc Capital Markets, Siebert Williams Shank & Co LLC, and Wells Fargo Securities LLC.

Ibotta Inc (Ticker: IBTA US) is set to go public with an IPO on the New York Stock Exchange, aiming to raise $472.5 million by offering 5,625,000 shares at a price range of $76.00 to $84.00.

The company, operating in the Applications Software industry, is known for its technology platform that enables consumers to earn cash back on purchases through partnerships with major retailers and consumer packaged goods (CPG) brands, including Walmart and Dollar General.

Ibotta has demonstrated significant financial growth, reporting $320 million in revenue for 2023, a 52% increase from the previous year, and a net income of $38.1 million, marking an improvement from previous losses. The company plans to use the funds raised for general corporate purposes and potential strategic investments. The offering is managed by Goldman Sachs, BofA Securities, and Citigroup Global Markets Realty Corp. Ibotta's IPO is anticipated for April 17, 2024, showcasing its role in performance marketing and its impact on the digital promotions and rewards sector.

UL Solutions Inc. (Ticker: ULS US) is preparing for an initial public offering (IPO) with plans to offer 28 million shares priced between $26 and $29, which could raise around $770 million. Founded in 1894 and headquartered in Northbrook, Illinois, UL Solutions provides testing, inspection, and certification services on a global scale. The company has a customer base exceeding 80,000 across more than 110 countries. For the 12-month period ending September 30, 2023, UL Solutions reported revenues of $2.623 billion and a net income of $296 million.

The company employs approximately 14,473 individuals. UL Solutions will not receive proceeds from the IPO, as the offering is made by its parent, ULSE Inc. (UL Standards & Engagement). Goldman Sachs and J.P. Morgan are managing the IPO, which is scheduled to be listed on the NYSE on April 12, 2024.

PACS Group (Ticker: PACS US) is a healthcare services company specializing in skilled nursing care. The company operates over 200 facilities across nine states, serving more than 20,000 patients. It focuses on acquiring underperforming long-term custodial care skilled nursing facilities and transforming them into higher acuity, short-term transitional care skilled nursing facilities. PACS Group emphasizes a decentralized model, empowering local facility leadership for autonomy in operations. For FY2023, the company reported $3.1 billion in revenue and a net income of $112.9 million.

PACS Group will list on the NYSE on April 11, 2024. The firm is selling 19,050,000 shares at a price range of $20.00 to $22.00, planning to raise about $419 million. The IPO is managed by Citi, JPMorgan, Truist Securities, and RBC Capital Markets, along with co-managers KeyBanc Capital Markets, Oppenheimer & Co., Regions Securities LLC, and Stephens Inc.

The company plans to use the IPO proceeds primarily for debt repayment and to allocate some funds for corporate growth and potential acquisitions. Founders will retain approximately 87.1% voting power post-IPO. IPO risks include dependence on third-party payor reimbursement, staffing challenges, regulatory compliance, and control by founders post-offering.

Contineum Therapeutics, Inc. (Ticker: CTNM US) is a biotechnology company based in the United States, specializing in the discovery and development of novel, oral small molecule therapies for neuroscience, inflammation, and immunology (NI&I) indications, including idiopathic pulmonary fibrosis (IPF) and progressive multiple sclerosis (Progressive MS). The company's lead asset, PIPE-791, is a brain-penetrant, small molecule inhibitor targeting the lysophosphatidic acid 1 receptor (LPA1R), with ongoing development for both IPF and Progressive MS.

Additionally, Contineum Therapeutics is advancing PIPE-307, a novel inhibitor of the muscarinic type 1 M1 receptor (M1R), for the treatment of depression and relapsing-remitting MS (RRMS), in collaboration with Johnson & Johnson.

Established in 2009, Contineum Therapeutics’ IPO, managed by Goldman Sachs (Left Lead), Morgan Stanley, RBC Capital Markets, and Stifel, is set to occur on April 5, 2024, with the company offering 8.8 million shares priced between USD 16.00 and USD 18.00, aiming to raise approximately USD 158.4 million. The firm operates out of San Diego, California, and as of the last 12 months, reported revenues of USD 50 million and a net income of USD 22.72 million.

BBB Foods Inc (Ticker: TBBB US) is a food wholesale and distribution company based in Mexico, specializing in operating a "hard discount" retail store chain akin to the models of Aldi and Lidl. The company is set to list on the New York Stock Exchange on February 9, 2024. BBB Foods Inc plans to offer 28.05 million Class A shares, with a price range set at USD 14.50 to 16.50, aiming to raise up to USD 462.83 million. The offering is managed by BofA Securities, Scotiabank de Puerto Rico, and UBS Investment Bank/US, among others. The company aims for a market capitalization of up to USD 1.85 billion if the offer is priced at the higher end of the range. BBB Foods plans to use the majority of the IPO proceeds to repay debt. As of the end of 2023, the company operated 2,288 stores across Mexico and reported a net loss of USD 10.79 million on revenue of USD 2.34 billion for the 12-month period ending September 30, 2023.

Metagenomi Inc (Ticker: MGX US) is a United States-based biotechnology company focused on advancing the field of gene editing through its innovative metagenomics-powered discovery platform. The company is scheduled to launch its initial public offering on the NASDAQ exchange, with an anticipated trading date of February 9, 2024. Metagenomi aims to raise USD 106.25 million by offering 6.25 million shares, with an expected price range of USD 15.00 to 17.00 per share. The offering includes a greenshoe option of 937,500 additional shares, potentially increasing the total offering size. The IPO is managed by a syndicate led by JP Morgan Securities LLC, alongside BMO Capital Markets Corp, Cowen & Co, Jefferies LLC, and Wells Fargo Securities LLC.

Metagenomi specializes in developing potentially curative therapies using next-generation gene editing technology. The company's research focuses on a wide array of diseases, including metabolic disorders, hemophilia A, cardiovascular diseases, central nervous system diseases, and cystic fibrosis, with all projects currently in preclinical development stages. Additionally, Metagenomi's platform targets immuno-oncology for ex vivo applications.

Kyverna Therapeutics, Inc. (Ticker: KYTX), based in Emeryville, California, is set for its IPO on the NASDAQ exchange, aiming to list on February 8, 2024. This clinical-stage biopharmaceutical company is dedicated to developing cell therapies for patients with autoimmune diseases, focusing initially on lupus nephritis (LN) and systemic sclerosis (SSc). Kyverna Therapeutics plans to offer 11.12 million shares, with a price range of $17.00 to $19.00, seeking to raise approximately $200.16 million.

The company's leading product candidate, KYV-101, is an autologous CD19 CAR T-cell therapy, showing promise in early clinical trials for its potential to modify diseases by depleting B cells, which contribute to autoimmune diseases. In partnership with Intellia Therapeutics, Inc., Kyverna is also developing KYV-201, an allogeneic CD19 CAR T-cell product candidate, expanding their approach to include off-the-shelf cell therapy options.

The offering is managed by by J.P. Morgan, Morgan Stanley, Leerink Partners, and Wells Fargo Securities.

Alto Neuroscience Inc (Ticker: ANRO US) is a biotechnology company specializing in the development of personalized and highly effective treatment options for mental health conditions. Utilizing an AI-enabled biomarker platform, Alto Neuroscience combines information on patients' brain activity and behavior to match patients with the most suitable product candidates, aiming to improve neuropsychiatric care.
Alto Neuroscience Inc will list on the New York Stock Exchange in the United States. The firm plans to offer 6.7 million shares, with an expected price range of USD 14.00 - 16.00 per share. The total offer size is estimated to be USD 107.20 million. The offering is managed by Jefferies & Co (Left Lead), Cowen & Co, Stifel Nicolaus & Co Inc, and William Blair & Co LLC. The company also includes a greenshoe facility of 15%, amounting to 1.0 million shares. Alto Neuroscience expects to commence trading on February 2, 2024.

Fractyl Laboratories Inc (Ticker: GUTS US) is a healthcare-provision company focused on developing innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company aims to transform metabolic disease treatment by targeting the root causes of these conditions at the organ level, moving beyond symptomatic management towards more durable, disease-modifying approaches.

Fractyl Laboratories Inc will list on the NASDAQ Global Market in the United States. The company expects to raise USD 117.33 million through its initial public offering. It is offering 7.33 million shares with an expected price range of USD 14.00 to 16.00 per share. Additionally, there is a greenshoe option of 15%, corresponding to 1.10 million shares. The expected trading date is set for February 2, 2024.

Fractyl Laboratories’ pipeline consists of two treatments: Revita®, an ablative procedure to remove unhealthy mucosal membranes in the gut, currently for investigational use only in the U.S., and Rejuva®, which is a GLP-1 diabetes treatment gene therapy in early development.

ZKH Group Ltd (Ticker: ZKH US) is a maintenance, repair, and operations (MRO) procurement service firm based in China. The company's primary business includes a digital procurement network supported by distribution centers, warehouses, and smart vending machines, supplying industrial customers with spare parts, chemicals, manufacturing parts, general consumables, and office supplies. According to the firm, ZKH Group Ltd has a substantial customer base with a high retention rate and operates an efficient, nationwide fulfillment network in China.

ZKH Group Ltd is scheduled to list on the New York Stock Exchange on December 15, 2023. The entity that is registered in the Cayman Islands (i.e. not the underlying business in China) plans to offer 4.00 million American Depositary Shares (ADS) in its IPO, with each ADS representing 35 Class A ordinary shares. The expected price range for the offering is USD 15.50 to 17.50 per ADS, aiming to raise approximately USD 70.00 million. The company has appointed Deutsche Bank, China Renaissance Securities HK Ltd, and CICC as the managers of the offering.

DDC Enterprise Ltd (Ticker: DDC US), also known as DayDayCook, is a company operating in the E-Commerce/Services industry, with a focus on promoting Asian cooking globally through its content-driven consumer brand. Based in Hong Kong, DayDayCook specializes in ready-to-heat (RTH), ready-to-cook (RTC), and ready-to-eat (RTE) products, targeting Millennial and Generation Z customers. The company announced its initial public offering (IPO) on July 25, 2023, and is set to list on the New York Stock Exchange American (NYSEAmerican) on November 17, 2023.

The IPO was initially planned to offer 4.25 million Class A ordinary shares within the price range of $9.50 to $11.50. However, the offering was priced below this range at $8.50 per share, resulting in a downsized IPO of 3.9 million shares, raising a total of $33.15 million. The market capitalization at the offer is estimated at $163.91 million. DDC Enterprise Ltd has also granted the underwriters a 30-day option to purchase an additional 585,000 shares at the IPO price, less underwriting discounts and commissions.

The offering is managed by CMB International Capital Corp Ltd (Left Lead), The Benchmark Company Inc., Freedom 3 Capital LLC, and Maxim Group LLC.

Hamilton Insurance Group Ltd (Ticker: HG US) is a Property/Casualty Insurance company. Founded in Bermuda in 2013, it has underwriting operations in Lloyd’s of London, Ireland, Bermuda, and the United States. The company operates through two main segments: International, accounting for 57% of 2022's gross premiums, and Bermuda, comprising 43%.

Hamilton Insurance Group Ltd will list on 11/10/23 on the New York Exchange. The firm is offering 15.0 million shares at an expected price range of USD 16.00 - 18.00. The total anticipated offer size is USD 270.00M and a market cap of approximately USD 1.8B. The IPO is overseen by Barclays Capital (Left Lead) and Morgan Stanley & Co LLC.

ANL US

Exp Price Range USD 22.00 - 26.00

Filing Amount USD 78.00M

Shares Offered 3.00M

SUPCON SW
Offer Price USD 26.94
Pre Shoe Amount USD 564.61M
Shares Offered Upsized 20.96M

ISPR US
Offer Price USD 7.00
Pre Shoe Amount USD 31.15M
Shares Offered 4.45M

TXO US
Offer Price USD 20.00
Pre Shoe Amount USD 100.00M
Shares Offered   5.00M

MBLY US
Exp Price Range USD 18.00 - 20.00
Filing Amount USD 820.00M
Shares Offered 41.00M

ECBK US
Exp Price Range USD 10.00 - 10.00
Filing Amount USD 106.38M
Shares Offered 10.64M